AMSBIO have introduced a new range of proprietary reagents designed for researchers investigating targeted cancer therapy. Targeted cancer therapy represents a promising new cancer treatment, one which delivers drugs in specific carriers and interferes with the specific target molecules that play a critical role in tumour growth and progression. Exosomes expressing specific surface markers (among them CD81, CD63, […]
Pay Invoice
Latest Blogs
-
Spatial Biology and Spatial Omics Imaging Systems
November 29, 2023 6:34 pm
-
Bioprocessing Analytical Technologies: Enabling Biopharma Production
October 17, 2023 6:31 pm
-
BioEcho Brings New Solutions to Nucleic Acid Extraction
September 21, 2023 3:24 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.